Prolactinoma in Women with Microprolactinoma and No Desire for Pregnancy

Clinical Scenario

This protocol applies to premenopausal and postmenopausal women diagnosed with a microprolactinoma who do not desire pregnancy. Because fertility is not a treatment goal, the management pathway differs substantially from approaches used in women who wish to conceive.

Specific Situation

Among premenopausal women with microprolactinoma and no pregnancy goal, gonadal function status is a key factor that shapes the appropriate approach. Some women in this group have altered gonadal function; others have normal gonadal function and may be candidates for a different pathway.

Postmenopausal women with microprolactinoma often present with mild to moderate prolactin elevation, and the need for active intervention in this subgroup is not always established.

Management Approach

For certain women in this setting, hormone replacement forms part of the management approach. The full protocol specifies when this applies and when a structured observation pathway is appropriate instead.

Complete regimen detail — including thresholds, sequencing, and evidence grading — is available via the link below.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1038/s41574-023-00886-5

Unless pregnancy is desired, management of premenopausal women with microprolactinoma should include the option of adequate sex hormone replacement without other interventions (strong).
Women with hyperprolactinaemia, microprolactinoma and normal gonadal function can be followed by observation (weak).
Postmenopausal women with microprolactinoma, who usually present with mild to moderate prolactin elevation, might not require intervention and can be observed by annual prolactin evaluation (weak).

View source ↗